This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • Genomic Biomarker Testing
      • PEACE-3 Trial
      • PROfound Trial
      • PSMAfore Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
      • CAPItello-281 Trial
      • PSMAddition Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
      • BOND-003 Cohort P
      • CORE-001 Study
      • CORE-008
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Daniel D. Joyce, MD, MS
        • Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
            Ashish Kamat, MD
          • Muscle-Invasive Bladder Cancer
          • Advanced & Metastatic Bladder Cancer (mUC)
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher® Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • mCRPC with Bone Metastasis
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • Testicular, Penile & Rare GU Malignances
        • Testicular Cancer
    • Functional Urology
      • Functional Urology
        Alan J. Wein, MD, PhD (hon.)
      • Urologic Catheters - CAUTI Challenges
  • Videos
    • Exclusives
      • Conferences
      • Disparities: Social Determinants of Health
      • Exclusive Collaborations
      • Health Policy in Urological Diseases
      • Independent Medical Education
      • Journal Clubs
      • Practice Guidelines Reviews
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Functional Urology
      • Men's Health
      • Pelvic Health
  • Actionable Clinical Data
    • Bladder Cancer
      • NMIBC with CIS: Evidence, Practice & Emerging Research
      • Risk-Stratified NMIBC Management
  • Trials in Progress
    • Prostate Cancer
      • Localized Prostate Cancer
        • CLARIFY
        • ESCAPE
        • FORT
        • NRG-GU 0101
        • RTIRE
      • High Risk BCR HSPC
        • ARASTEP
      • Oligometastatic Prostate Cancer
        • METANOVA
      • mHSPC
        • ARASEC
        • ASPIRE
        • MEVPRO-3
      • mCRPC
        • ECLIPSE
        • LEGION-100
        • MEVPRO-1 & 2
        • PROMISE
        • SECuRE
    • Bladder Cancer
      • PIVOT-006
    • Kidney Cancer
      • RadiCal
      • SAMURAI
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SNMMI 2026
      • ASCO 2026
      • AUA 2026
      • APCCC 2026
      • PSMA and Beyond 2026
    • All Conferences
      • View All
  • PCF
  1. UroToday Home

UroToday Site Search

8 Results
Abstract
Accurate Assessment of Interval Change in Stone Burden Among Patients with Medullary Sponge Kidney: A Volumetric Approach.
Introduction: Medullary sponge kidney (MSK) and nephrocalcinosis (NC) are radiographically characterized by the formation of innumerable intrarenal concretions. Accurate determination of disease progression is challenging given the large and typically sporadic calcific burden, limiting the utility of traditional manual linear measurements on non-contrast computerized tomography (NCCT).. Progression of stone size or quantity is an important predi...
Last updated Aug. 11, 2025
Conference Coverage
AUA 2025: Crossfire: Controversies in Urology: Battle of the Guidelines: Examining Key Differences in Evidence-Based Urethral Stricture Management.
(UroToday.com) Tuesday morning’s plenary session featured an excellent crossfire debate on the management of urethral stricture disease. The session compared three sets of global guidelines: the American Urological Association (AUA), European Association of Urology (EAU), and Urological Society of India (USI). Dr. Kenneth Angermeier from the Cleveland Clinic moderated the session, which included panelists Ms. Tamsin Greenwell (EAU), Dr. Pankaj...
Last updated Apr. 30, 2025
Conference Coverage
AUA 2025: State-Of-The-Art Lecture: A Perfect Storm: The Timing, Scope, and Spectrum of Radiation-Induced Complications after Prostate Cancer Treatment
(UroToday.com) Dr. Keith Rourke from the University of Alberta presented on the topic of radiation-induced complications after prostate cancer (PCa) treatment. Dr. Rourke began by highlighting how it has become clear that the long term cancer specific survival for localized PCa is robust. The ProtecT trial demonstrated a 15-year cancer specific survival of over 95% regardless of treatment modality. The 20-year cancer-specific survival is around...
Last updated Apr. 30, 2025
Conference Coverage
EUS 2025: A Steerable Kidney Stone Basket
(UroToday.com) While kidney stone removal is a standard clinical procedure, surgeons can encounter stones that lie in recessed areas that are challenging to reach. Particularly, stones which are present in the lower pole (accounting for 25-35% of all kidney stones) 1 can be difficult due to anatomical constraints and the limited maneuverability of existing ureteroscopes and ureteroscopic tools. Mr. Connor and his team hypothesized that an indepe...
Last updated Apr. 29, 2025
Conference Coverage
AUA 2025: Second Opinion Cases: Penile Fracture
(UroToday.com) Monday afternoon’s plenary session continued with a case series of penile fractures of different etiologies. A penile fracture is a rupture of the tunica albuginea, typically caused by blunt trauma to an erect penis, often during vigorous sexual intercourse or upon penetration. It typically presents with a characteristic “popping” sound, immediate detumescence, swelling, and bruising, and usually requires urgent surgical rep...
Last updated Apr. 29, 2025
Video
Prospective Randomized Evaluation of Viewing CT-Based Immersive Virtual Reality Imaging Prior To Laparoscopic/Robotic Partial Nephrectomy: Impact on Surgical Planning and Outcomes "Presentation" - Eman Chaudhri
Eman Chaudhri discusses a randomized study of 32 patients with T1a renal masses which shows that supplementing standard CT imaging with immersive virtual reality models significantly improves surgical planning for partial nephrectomy. The clinical benefits are substantial, with the CT-plus-iVR group experiencing a 48-minute reduction in operative time compared to the CT-only group. Biography: Eman N. Chaudhri, MD, Department of Urology, Universi...
Last updated Nov. 18, 2025
Conference Coverage
AUA 2025: Confederación Americana de Urología (CAU) Lecture: Male Voiding Dysfunction: Beyond the Prostate
(UroToday.com) Sunday afternoon’s plenary session continued with an insightful talk by Dr. José Carlos Truzzi from the Federal University of Sao Paulo. Dr. Truzzi began the session with a brief history of the general understanding of male voiding dysfunction. What was once understood as “prostatism” is nowadays better understood as lower urinary tract symptoms, or “LUTS” through a paradigm shift that occurred over the 1990s. “LUTS...
Last updated Apr. 28, 2025
Conference Coverage
AUA 2025: Crossfire: Controversies in Urology: Single Port vs Multiport Robotic Surgery
(UroToday.com) Saturday afternoon’s plenary session continued with an excellent presentation by Dr. Li-Ming Su regarding controversies around single-port vs multi-port robotic surgery. Dr. Su put together a world class panel of urologists from across the globe to discuss the pros and cons of adoption of and surgical practice with single-port (SP) versus multi-port (MP) robotic surgery, and which could be deemed preferable by urologists.. Dr. Su...
Last updated Apr. 27, 2025
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2026 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free